Although the scientific relevance in the aforementioned cardiovascular threat factor alterations by tirzepatide will probably be assessed while in the planned cardiovascular final result research SURPASS-CVOT ( "variety":"clinical-demo","attrs": "textual content":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular met